Back to Screener

Sotera Health Company Common Stock (SHC)

Price$15.83

Favorite Metrics

Price vs S&P 500 (26W)-3.80%
Price vs S&P 500 (4W)10.76%
Market Capitalization$4.56B
P/E Ratio (Annual)58.48x

All Metrics

P/CF (Annual)15.87x
Book Value / Share (Quarterly)$2.13
P/TBV (Annual)15.45x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)5.05%
Cash Flow / Share (Quarterly)$0.52
Price vs S&P 500 (YTD)-11.77%
Gross Margin (TTM)55.48%
Net Profit Margin (TTM)6.70%
EPS (TTM)$0.27
10-Day Avg Trading Volume2.89M
EPS Excl Extra (TTM)$0.27
Revenue Growth (5Y)7.30%
EPS (Annual)$0.27
ROI (Annual)2.74%
Gross Margin (Annual)55.48%
Net Profit Margin (5Y Avg)0.98%
Cash / Share (Quarterly)$1.21
P/E Basic Excl Extra (TTM)58.48x
Revenue Growth QoQ (YoY)4.56%
P/E Normalized (Annual)58.48x
ROA (Last FY)2.39%
Revenue Growth TTM (YoY)5.74%
EBITD / Share (TTM)$1.17
ROE (5Y Avg)-2.27%
Operating Margin (TTM)25.41%
Cash Flow / Share (Annual)$0.52
P/B Ratio7.52x
P/B Ratio (Quarterly)8.27x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)5.54x
Net Interest Coverage (TTM)1.94x
ROA (TTM)2.44%
EPS Growth QoQ (YoY)181.21%
EV / EBITDA (TTM)19.27x
EPS Incl Extra (Annual)$0.27
Current Ratio (Annual)2.46x
Quick Ratio (Quarterly)2.15x
3-Month Avg Trading Volume2.49M
52-Week Price Return50.94%
EV / Free Cash Flow (Annual)43.25x
P/E Incl Extra (TTM)58.48x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.14
P/S Ratio (Annual)3.92x
Asset Turnover (Annual)0.36x
52-Week High$19.85
Operating Margin (5Y Avg)16.35%
EPS Excl Extra (Annual)$0.27
CapEx CAGR (5Y)20.87%
26-Week Price Return0.19%
Quick Ratio (Annual)2.15x
13-Week Price Return-15.59%
Total Debt / Equity (Annual)3.69x
Current Ratio (Quarterly)2.46x
Enterprise Value$6,452.181
Revenue / Share Growth (5Y)7.27%
Asset Turnover (TTM)0.36x
Book Value / Share Growth (5Y)5.94%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)10.01x
Pretax Margin (Annual)12.68%
Cash / Share (Annual)$1.21
3-Month Return Std Dev33.56%
Gross Margin (5Y Avg)55.28%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)7.80%
EBITDA Interim CAGR (5Y)31.32%
ROE (Last FY)12.86%
Net Interest Coverage (Annual)1.94x
EPS Basic Excl Extra (Annual)$0.27
P/FCF (TTM)30.56x
Receivables Turnover (TTM)7.29x
EV / Free Cash Flow (TTM)43.25x
Total Debt / Equity (Quarterly)3.69x
EPS Incl Extra (TTM)$0.27
Receivables Turnover (Annual)7.29x
ROI (TTM)2.79%
P/S Ratio (TTM)3.92x
Pretax Margin (5Y Avg)5.55%
Revenue / Share (Annual)$4.06
Tangible BV / Share (Annual)$1.14
Forward P/E16.42x
Free OCF CAGR (5Y)17.33%
Price vs S&P 500 (52W)21.11%
P/E Ratio (TTM)58.48x
EPS Growth TTM (YoY)52.47%
Year-to-Date Return-9.13%
5-Day Price Return4.91%
EPS Normalized (Annual)$0.27
ROA (5Y Avg)0.44%
Net Profit Margin (Annual)6.70%
Month-to-Date Return11.79%
Cash Flow / Share (TTM)$-0.55
EBITD / Share (Annual)$1.17
EPS Growth (3Y)-28.06%
Operating Margin (Annual)25.41%
LT Debt / Equity (Annual)3.51x
P/CF (TTM)15.87x
ROI (5Y Avg)0.25%
P/E Excl Extra (TTM)58.48x
LT Debt / Equity (Quarterly)3.51x
EPS Basic Excl Extra (TTM)$0.27
P/TBV (Quarterly)15.45x
P/B Ratio (Annual)8.27x
Inventory Turnover (TTM)10.01x
Pretax Margin (TTM)12.68%
Book Value / Share (Annual)$2.13
Price vs S&P 500 (13W)-16.27%
Beta1.90x
P/FCF (Annual)30.56x
Revenue / Share (TTM)$4.05
ROE (TTM)14.98%
52-Week Low$10.17

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.20
4.20
4.20

Industry Peers — Health Services(14)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
SHCSotera Health Company Common Stock
58.48x5.74%25.41%14.98%$15.83
FMSFresenius Medical Care AG
11.49x1.51%9.31%7.26%$22.77
DVADaVita Inc.
12.86x6.46%14.88%181.22%$148.13
PGNYProgyny, Inc. Common Stock
24.34x10.40%6.62%11.37%$17.93
MCTACharming Medical Limited Class A Ordinary Shares
414.66x15.45%$29.36
AGLagilon health, inc.
-2.11%-7.81%-116.65%$30.94
VMDViemed Healthcare, Inc. Common Shares
24.84x20.52%8.49%10.87%$9.57
QIPTQuipt Home Medical Corp. Ordinary Shares
9.52%-1.22%-10.47%$3.65
PARKPark Dental Partners, Inc. Common Stock
17.91x0.10%$18.02
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares
174.54x-0.64%$12.20
OAKUROak Woods Acquisition Corporation Right
174.54x-0.64%$0.16

About

Sotera Health Co provides sterilization and analytical testing services for medical devices, pharmaceuticals, and food products. The company operates through three segments: Sterigenics, which dominates revenue through terminal sterilization using gamma irradiation, EO processing, and E-beam technologies; Nordion; and Nelson Labs. Geographically, the company generates primary revenue from the United States, with additional operations in Canada, Europe, and other regions.